Report of NRG Oncology/RTOG 9601, A Phase 3 Trial in Prostate Cancer: Anti-androgen Therapy (AAT) With Bicalutamide During and After Radiation Therapy (RT) in Patients Following Radical Prostatectomy (RP) With pT2-3pN0 Disease and an Elevated PSA.

Authors :: Shipley, W.U.
Seiferheld, W.
Lukka, H.
Major, P.
Heney, N.M.
Grignon, D.
Sartor, O.
Patel, M.
Bahary, J.P.
Zietman, A.L.
Pisansky, T.M.
Zeitzer, K.L.
Lawton, C.A.F.
Feng, F.Y.
Lovett, R.D.
Balogh, A.
Souhami, L.
Rosenthal, S.A.
Kerlin, K.J.
Sandler, H.M.
Source :: International Journal of Radiation Oncology, Biology, Physics. Jan2016, Vol. 94 Issue 1, p3-3. 1p.
Publication Year :: 2016

Subjects :: *PROSTATE cancer
*ONCOLOGY
*ANTIANDROGENS
*CANCER radiotherapy
*PROSTATECTOMY

Full Text Access

Tools